TrkB agonist is shown to partially reverse cerebellar malformations at the levels of cytoarchitecture and motor behavior in Rbm4 knockout mice, suggesting that RBM4 plays a role in cerebellar development and functions through the BDNF-TrkB signaling pathway.
- Yu-Young Tsai
- Chiu-Lun Shen
- Woan-Yuh Tarn